Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban

Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist oral anticoagulants (NOACs). The objective of this retrospective claims observational cohort study was to compare the risk of bleeding among non-valvular atrial fibrillation (NVAF) patients prescribed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Tepper, Ping G., Mardekian, Jack, Masseria, Cristina, Phatak, Hemant, Kamble, Shital, Abdulsattar, Younos, Petkun, William, Lip, Gregory Y. H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6211674/
https://ncbi.nlm.nih.gov/pubmed/30383768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0205989
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares